AL-1311

N/A

Report date: 2023/08/30 17:08:04
NME

Base Information

Drug NameAL-1311
Drug Alias NameAL-1311AL1311
ClassificationOther
Mechanisms of ActionNuclear factor erythroid 2-related factor 2 activators
TargetsNuclear factor erythroid 2-related factor 2
Therapy Area/IndicationsPolycystic Kidney, Autosomal Dominant
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAceLink Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAceLink Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsPolycystic Kidney, Autosomal Dominant
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A